Top Vaccines companies in Hong Kong by EBITDA

This ranking features the top 4 Vaccines companies in Hong Kong ranked by EBITDA, totaling a EBITDA of USD 80.44 M, for February 04, 2025.

Hong Kong

Vaccines
EBITDA
#
Name
EBITDA
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
0013.HK

HUTCHMED (China) Limited

1

0013.HK
USD 67.27 M
Dec. 31, 2023 USD 2.68 -1.44%

Hong Kong
2
1521.HK

Frontage Holdings Corporation

2

1521.HK
USD 45.02 M
Dec. 31, 2023 USD 0.22 -1.18%

Hong Kong
3
RGC

Regencell Bioscience Holdings Limited

3

RGC
USD -3.62 M
June 30, 2024 USD 3.80 0.53%

Hong Kong
4
3681.HK

SinoMab BioScience Limited

4

3681.HK
USD -28.24 M
Dec. 31, 2023 USD 0.13 -0.02%

Hong Kong
Frequently Asked Questions
  • Which Vaccines company in Hong Kong has the highest EBITDA ?

    The Vaccines company in Hong Kong with the highest EBITDA is HUTCHMED (China) Limited (HKSE: 0013.HK) at USD 67.27 M.

  • Which Vaccines company in Hong Kong has the lowest EBITDA ?

    The Vaccines company in Hong Kong with the lowest EBITDA is SinoMab BioScience Limited (HKSE: 3681.HK) at USD -28.24 M.

SV Wall Street